IO Biotech, Inc.
Recent Filings
All 264 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Feb 13, 2026 |
| 8-K | 8-K | Feb 13, 2026 |
| SCHEDULE 13G | — | Feb 6, 2026 |
| 8-K | 8-K | Jan 30, 2026 |
| SCHEDULE 13D/A | — | Jan 23, 2026 |
| 8-K | 8-K | Jan 21, 2026 |
| 8-K | 8-K | Dec 19, 2025 |
| 8-K | 8-K | Nov 21, 2025 |
| 8-K | 8-K | Nov 18, 2025 |
| SCHEDULE 13G/A | — | Nov 14, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Hunter Heidi | — | Purchase | 15,000 @ $1.39 | 15,000 | May 30, 2025 |
| Ahmad Qasim Iftikhar | Chief Medical Officer | Purchase | 31,350 @ $0.85 | 31,350 | Dec 23, 2024 |
| Zocca Mai-Britt | Chief Executive Officer | Purchase | 12,500 @ $0.81 | 49,891 | Dec 23, 2024 |
| Sullivan Amy | Chief Financial Officer | Purchase | 10,250 @ $0.83 | 84,632 | Dec 23, 2024 |
| Smith Devin Whittemore | General Counsel | Purchase | 12,000 @ $0.81 | 16,938 | Dec 23, 2024 |
| Novo Holdings A/S | — | Sale | 23,478 @ $1.31 | 4,354,449 | Jul 25, 2024 |
| Novo Holdings A/S | — | Sale | 658,809 @ $1.22 | 4,429,449 | May 10, 2024 |
| Novo Holdings A/S | — | Sale | 658,809 @ $1.50 | 5,088,258 | Feb 9, 2024 |
| Burkavage Brian | Chief Accounting Officer | Purchase | 5,000 @ $1.04 | 11,500 | Nov 21, 2023 |
| Smith Devin Whittemore | General Counsel | Award / Grant | 4,938 @ $1.90 | 4,938 | Aug 9, 2023 |